10times
28 - 29 Apr 2021Ended

Global NASH Congress

AboutSpeakersExhibitorsReviewsPhotos

Timings

09:00 AM - 06:00 PM
Not Verified

Official Links

Estimated Turnout

upto 100
Delegates
Based on previous editions

Editions

Apr 2021

Frequency

Not Available
Claim event to edit details

The conference examined the latest research and development in pathogenesis, diagnosis and treatment of the disease. As well as exceptional speaker .. Read more presentations the meeting featured 10 roundtable discussions. “I really enjoyed the scientific content of the conference with news from providers and Pharma organisations.” Delegate Pharma Company “There was a good variety of speakers & content with ample networking opportunities” NHS Delegate “A very good spread of content with topics that were applicable to a wide audience.”Academic delegate “Well organised, varied content covering the main aspects of NASH and drug development.” Speaker “I appreciated the broad spectrum of areas within NASH from clinical trials and biomarker to scientific new projects. The conference provided a nice overview of the field as of today.” Sponsor. “I appreciated the broad spectrum of areas within NASH from clinical trials and biomarker to scientific new projects. This session will compose of an overview of what was learned from phase 2/3 trials in 2019 followed by a series of flash presentations where clinical trial data sets will be presented. Research Director of Cardiometabolic Risk Unit, Institute of Clinical Physiology, CNR, Pisa Italy & Professor of Medicine, UT Health Science Center San Antonio, TX, USA.

  • Share your Experience
  • Organizer
Logo Follow Company

Global Engage

UK105 Total Events / 14 Upcoming Events

More Events From The Organizer